Company Description
UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.
UHN’s vision is to build A Healthier World and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.
www.uhn.ca
Job Description
Number of vacancies: 1
New or Replacement Position: New
Site: Mars/Hybrid
Department: Commercialization, Peter Gilgan Centre for Early Cancer Detection Research at Princess Margaret Cancer Centre
Reports to: Director, Commercialization
Salary Range: $138,185 to $172,731 per annum
Hours: 37.5 hours
Status: Permanent Full-Time
Closing Date: December 7, 2026
Position Summary
We are seeking an experienced, strategic, and entrepreneurial business development and commercialization professional to advance UHN’s clinical commercialization agenda in the area of clinical research across two complementary portfolios: the Peter Gilgan Centre for Early Cancer Detection Research and UHN’s extensive clinical research areas for clinical trials. This role is focused on building clinically anchored research commercialization opportunities, advancing investigator-initiated and industry-partnered clinical trials, and structuring risk-sharing partnerships that translate UHN’s clinical and research strengths into patient impact at a global scale, and sustainable value.
Within the broader clinical research commercialization portfolio, the Principal will work closely with the various Clinical Research Units to identify and advance commercialization and industry-partnership opportunities arising from its clinical research activities, investigator-initiated trials, clinical infrastructure, and relationships with clinical research teams. This work is complementary with the Peter Gilgan Centre for Early Cancer Detection Research, which will focus specifically on opportunities arising from the Centre’s research portfolio, technologies, programs, and strategic priorities. Across both portfolios, the Principal will provide coordinated business development and commercialization leadership to the mandates, stakeholders, and opportunity pipelines of each area.
You will work across these complementary portfolios to identify, evaluate, develop, and execute high-value opportunities involving clinical trials, diagnostics, platform technologies, strategic collaborations, and other healthcare innovations. The successful candidate will serve as a key bridge amongst investigators, clinicians, industry and funding partners, legal and contracting teams, and UHN commercialization colleagues to move opportunities from concept through partnership, deal completion, and post-execution.
This role combines strategic leadership with hands-on business development and partnership execution. Responsibilities span broader clinical research and related areas, and are advanced in direct collaboration with the Clinical Research Units and commercialization leadership for the Peter Gilgan Centre for Early Cancer Detection Research. Responsibilities will include:
- Support the execution of UHN’s commercialization strategy in clinical research, advancing industry-supported investigator-initiated and industry-sponsored trials, clinically anchored research opportunities, early validation, and risk-sharing partnerships with industry across UHN and the Peter Gilgan Centre for Early Cancer Detection Research.
- Identify, assess, and advance a high-quality pipeline of clinical research, commercialization, and partnership opportunities aligned with UHN priorities, working with clinical and research teams to evaluate feasibility, funding, resource requirements, timelines, market potential, and commercialization pathways.
- Develop compelling business cases, value propositions, market assessments, commercialization plans, and partnership strategies for clinical trial assets, including clinical data and materials, diagnostics, biomarkers, liquid biopsies, molecular residual disease monitoring, AI-enabled detection, screening technologies, platform technologies, and other healthcare innovations.
- Contribute to the implementation and growth of the UHN Clinical Accelerator Fund, which advances innovations toward first-in-human studies, early clinical validation, and industry partnership, including risk-sharing and innovative funding models that leverage UHN’s clinical capabilities, patient access, clinical trial infrastructure, and translational expertise.
- Identify, cultivate, and manage relationships with biotechnology, pharmaceutical, and diagnostics companies, funding partners, and strategic partner organizations to secure partnerships, sponsorships, investment, and innovative funding arrangements that accelerate clinical innovation and commercialization.
- Evaluate, protect, and manage intellectual property arising from clinical research and the Peter Gilgan Centre for Early Cancer Detection Research, including reviewing invention and data disclosures, assessing patentability and commercial potential, advising on protection and IP strategy in coordination with patent counsel, and overseeing the IP portfolio through to licensing, option, or other commercialization outcomes.
- Structure, negotiate, and execute complex clinical research, collaboration, intellectual property, option, licensing, co-development, industry-sponsored, and commercialization agreements, including arrangements supporting molecular residual disease monitoring, platform trials, and related escalation or de-escalation trials.
- Serve as a trusted commercialization partner and advisor to clinicians, investigators, researchers, scientific leaders, and clinical research teams, supporting entrepreneurship and industry engagement initiatives that build commercialization awareness and capability across UHN.
- Collaborate closely with clinical operations, legal, regulatory, finance, compliance, data, contracting, licensing, and commercialization teams to move opportunities efficiently from concept through partnership, agreement, implementation, and impact.
Qualifications
- Minimum 10 years of experience in business development, licensing, strategic partnerships, commercialization, or related fields.
- Demonstrated experience working within a clinical research environment, including supporting clinical trials, investigator-initiated studies, translational research, research operations, or research program development.
- Advanced degree (PhD, MD, MBA, MSc, JD, or equivalent) in a relevant scientific, clinical, business, or technical field preferred. MD would be an asset.
- Experience negotiating and managing licensing transactions, research collaborations, industry-sponsored research agreements, and strategic partnerships.
- Strong understanding of intellectual property, commercialization strategy, technology development, and healthcare innovation ecosystems.
- Experience in oncology, diagnostics, biomarkers, precision medicine, cancer research, clinical trials, cancer screening, molecular diagnostics, or related translational medicine fields is strongly preferred.
- Experience supporting commercialization, partnership development, business development or research growth initiatives within healthcare, academic or industry research settings.
- Demonstrated ability to build partnerships across academic, clinical, industry, investor, and innovation ecosystems.
- Strong understanding of the clinical research lifecycle, including study development, feasibility assessment, regulatory requirements, study start-up, research conduct, and commercialization opportunities arising from clinical research, along with strong analytical and business case development skills.
- Exceptional communication, relationship-building, negotiation, and stakeholder management capabilities.
- Client service oriented, with the ability to effectively work with diversity and appreciate that people with different opinions, backgrounds and characteristics bring richness to the challenge or situation at hand. This includes a high EI/EQ in working with globally recognized clinical leaders.
- The successful candidate will bring commercial judgment, scientific credibility, and partnership-building skills to a high-impact role at the intersection of clinical innovation and commercialization.
Additional Information
Why join UHN?
In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.
- Competitive offer packages
- Close access to Transit and UHN shuttle service
- A flexible work environment
- Opportunities for development and promotions within a large organization
- Additional perks (multiple corporate discounts including: travel, restaurants, parking, phone plans, auto insurance discounts, on-site gyms, etc.)
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.
All applications must be submitted before the posting close date.
UHN uses email to communicate with selected candidates. Please ensure you check your email regularly. At University Health Network (UHN), artificial intelligence technologies may be used to assist in the screening, assessment, and selection of candidates for this position.
Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.
UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.
We thank all applicants for their interest, however, only those selected for further consideration will be contacted.
Department: Research Compensation: CAD 138185 - CAD 172731 - yearly